window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

European biotech funding

  • Biotech,Funding,Immunology,Oncology,Research & Development

    Laigo Bio raises €17m seed funding to advance oncology pipeline

    Laigo Bio has completed a €17 million seed financing round [...]

    March 23, 2026
  • European biotech,Partnerships & Funding,Research & Development,Technology and platforms

    Novo Nordisk Foundation commits DKK 5.5BN (EUR 736M) to BioInnovation Institute expansion

    The Novo Nordisk Foundation has committed up to DKK 5.5 [...]

    January 14, 2026
  • Biotech,European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics

    Sofinnova Partners closes €650m Capital XI to back early-stage healthcare deals

    Sofinnova Partners, a European life sciences venture capital firm with [...]

    November 17, 2025
  • Biotech,European biotech,Partnerships & Funding

    Medicxi closes €500 million fund to expand asset-centric biotech strategy

    Medicxi has closed a €500 million fund to advance its [...]

    November 14, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top